子周长与动脉动脉质指数与冠心病之间的相关性
Huihui Yang1, Jie Dou1, Ruoling Guo1
1Chengde Medical University Graduate School, Hebei, China.
Frontiers in endocrinology
|October 20, 2025
概括
子周长 (NC) 和血动脉动因子指数 (AIP) 与冠心病 (CHD) 有关. 结合这些措施可以提高诊断价值来识别心血管疾病,为风险评估提供了一种全新的方法.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 公共卫生 公共卫生
背景情况:
- 冠心病 (CHD) 是全球主要的死亡原因,在中国的患病率越来越高.
- 脱脂症与动脉样硬化发展有着强烈的关系.
- 了解冠心病的新风险因素和诊断标志物至关重要.
研究的目的:
- 调查子周长 (NC) 和动脉动脉质指数 (AIP) 与心脏病发病率和严重程度之间的关联.
- 评估NC和AIP在CHD检测中的联合诊断实用性.
主要方法:
- 一项观察性,横截面研究,涉及1652名胸痛患者进行冠状动脉动脉扫描.
- 限制立方线 (RCS) 用于分析NC,AIP和CHD之间的关联.
- 开发和验证使用回归分析和ROC曲线的风险预测名录.
主要成果:
- 在较高的NC四分位数和心血管疾病的几率增加之间发现了显著的积极关联 (p-trend = 0.030).
- 更高的NC四分位数也与冠状动脉病变的严重程度增加相关 (p趋势=0.039).
- 结合NC和AIP的诺米图显示了CHD的大量预测准确性 (AUC = 0.729).
结论:
- 子周长和血的动脉动脉生成指数与冠状动脉心脏病正相关.
- 结合NC和AIP的测量为CHD诊断提供了显著的预测价值.
相关概念视频
Coronary Artery Disease I: Introduction
876
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
876
Coronary Artery Disease III: Clinical Manifestations
322
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
322
Coronary Artery Disease IV: Preventive Measures
584
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
584
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
458
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
458
Coronary Artery Disease II: Pathophysiology
366
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
366
Atherosclerosis I: Introduction
904
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
904


